Abstract
Autoimmune hepatitis (AIH)1-4, an inflammatory liver disease, represents histologically and serologically a broad spectrum of characteristic features. The classification of AIH is primarily based on serological criteria. Type I AIH is defined by antibodies to nuclei (ANA) and eventually actin, while type II AIH is characterized by antimicrosomal antibodies recognizing cytochrome P450IID62-6. Moreover, a substantial number of AIH patients7-11 produce antibodies to a cytosolic soluble antigen7-10, either alone or in combination with antinuclear and/or smooth muscle antibodies (SMA). One may assume that these patients represent a distinct AIH subgroup. However, two different cytosolic antigens have been described: liver-pancreas-specific antigen (LP)12 and soluble liver antigen (SLA)7. From originally described characteristics and a careful comparison of the isolation procedure it can be deduced that the antigens are identical. Both antigens were defined as non-species-, non-organ-specific, despite their highest concentration being in the liver. According to the published protocols they were obtained as a supernatant after extensive ultracentrifugation of the tissue9 homogenates, indicating their extremely high solubility. Moreover, both antigens represent a very heterogeneous fraction, consisting of at least 100 different proteins. Therefore, one might expect that human autoantibodies would exhibit specificity against more than a single antigen target.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mackay IR, Taft CO, Cowling DS. Lupoid hepatitis. Lancet. 1956;2:1323–1326.
Czaja AJ. Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig Dis Sci. 1995;40:435–456.
Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med. 1996;125:588–598.
Krawitt EL. Autoimmune hepatitis. N Engl J Med. 1996;334:897–903.
Smith MGM, Williams R, Walker R, Rizzetto M, Doniach D. Hepatic disorders associated with liver/kidney microsomal antibodies. Br Med J. 1974;2:80–84.
Homberg JC, Abuaf N, Bernard O et al. Chronic active hepatitis associated with anti-liver-kidney microsome antibody type 1: a second type of ‘autoimmune’ hepatitis. Hepatology. 1987;7:1333–1339.
Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde KH. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet. 1987;1:292–294.
Johnson PI, McFarlane IG, McFarlane BM, Williams R. Autoimmune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional autoantibodies. J Gastroenterol Hepatol. 1990;5:244–251.
Johnson PI, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998–1005.
Czaja AJ, Carpenter HA, Manns MR Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology. 1993;105:1522–1528.
McFarlane JG, Williams R. Historical overview. In: McFarlane JG, Williams R, editors. Molecular Basis of Autoimmune Hepatitis. Heidelberg: Springer-Verlag. 1996:1–21.
Stechenmesser E, Strienz J, Berg PA. Serological definition of a new subgroup of patients with autoimmune chronic active hepatitis. Lancet. 1987;1:683.
DeDuwe C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F. Tissue fractionation studies. Intracellular distribution patterns of enzymes in rat liver tissues. Biochem J. 1955;60:604–610.
Tata JR. Isolation of nuclei from rat liver and other tissues. Methods Enzymol. 1974;31:253–562.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685.
O’Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975;250:4007–4021.
Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210. J Exp Med. 1995;182:1159–1162.
Simons PC, Vander Jagt DL. Purification of glutathione S-transferases from human liver by glutathione-affinity chromatography. Analyt Biochem. 1977;82:334–341.
Wächter B, Kyriatsoulis A, Lohse AW, Gerken G, Meyer zum Büschenfelde KH, Manns M. Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. J Hepatol. 1990;11:232–239.
Franke WW, Schiller D, Moll R, Winter S, Schmid E, Engelbrecht I. Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol. 1981;153:933–959.
Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultures cells. Cell. 1982;31:11–24.
Chou Y-H, Rosevear E, Goldman RD. Phosphorylation and disassembly of intermediate filaments in mitotic cells. Proc Natl Acad Sci USA. 1989;86:1885–1889.
Stechenmesser E, Klein R, Berg PA. Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology. 1993;18:1–9.
Bass NM, Kirsch RE, Tuff SA, Marks I, Saunders SJ. Ligand in heterogeneity: evidence that the two non-identical subunits are the monomers of the two distinct proteins. Biochim Biophys Acta. 1977;492:163–175.
Hayes JD. Purification and characterization of glutathione S-transferases P, S, and N. Isolation from rat liver of Yb, Yn protein, the existence of which was predicted by subunit hybridization in vitro.Biochem J. 1984;224:839–852.
Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST* and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445–600.
Pickett CB, Telakowski-Hopkins CA, Ding GJ-F, Argenbright L, Lu AYH. Rat liver glutathione S-transferases. Complete nucleotide sequence of a glutathione S-transferase mRNA and the regulation of the Ya, Yb, and Yc mRNA by 3-methylcholanthrene and phenobarbital. J Biol Chem. 1984;259:5182–5188.
Telakowski-Hopkins CA, Rodkey JA, Bennett CD, Lu AYH, Pickett CB. Rat liver glutathione S-transferases. Construction of a cDNA clone complementary to a Yc mRNA and prediction of the complete amino acid sequence of a Yc subunit. J Biol Chem. 1985;260:5820–5825.
Smith GJ, Ohl VS, Litwack G. Ligandin, the glutathione S-transferases, and chemically induced hepatocarcinogenesis: a review. Cancer Res. 1977;37:8–14.
Wesierska-Gadek J, Grimm R, Hitchman E, Penner E. Members of the glutathione S-transferase gene family are antigens in autoimmune hepatitis. Gastroenterology, 1996;114:329–335.
Hayes PC, Portmann B, Aldis PM, Williams R, Hayes JD. In: Mantle TJ, Pickett CB, Hayes JD, editors. Glutathione S-transferases and Carcinogenesis. London: Taylor & Francis; 1987;175–187.
Mackay IR. The grey edges of autoimmune hepatitis. Intern Hepatol Commun. 1996;5:191–200.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Węsierska-Gądek, J., Penner, E. (2000). Reactivity of autoimmune hepatitis sera with glutathione S-transferase. In: Manns, M.P., Paumgartner, G., Leuschner, U. (eds) Immunology and Liver. Falk Symposium, vol 114. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4000-3_14
Download citation
DOI: https://doi.org/10.1007/978-94-011-4000-3_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5768-4
Online ISBN: 978-94-011-4000-3
eBook Packages: Springer Book Archive